Drug Repurposing for Alzheimer’s Disease Based on Protein-Protein Interaction Network

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Number of drugs</td><td class="align_center">Drug names</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">9</td><td class="align_center">Tamoxifen, verapamil, alteplase, raloxifene, hexachlorophene, nicotine, clozapine, estradiol, progesterone</td></tr><tr><td class="align_left">4</td><td class="align_center">Pilocarpine, doxorubicin, haloperidol, daunomycin</td></tr><tr><td class="align_left">1</td><td class="align_center">Gentian violet</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>A categorization of the extracted drugs.</div>

BioMed Research International

tab3

Table 3

Table 3: Drug Repurposing for Alzheimer’s Disease Based on Protein-Protein Interaction Network 